0 items

in your cart
$0.00

Drug Search > Irinotecan

Prescription Drug Search

Strengths available for Irinotecan injection:

Irinotecan injection 20mg/mL
Irinotecan injection 40mg/2mL
Irinotecan injection 100mg/5mL

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about ExpressMedsCanada.com

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Irinotecan:

  • Anguilla
  • Armenia
  • Aruba
  • Australia
  • Barbados
  • Bolivia
  • Croatia
  • Cyprus
  • Dominican Republic
  • European Union
  • Fiji
  • Finland
  • Georgia
  • Gibraltar
  • Greenland
  • Grenada
  • Hungary
  • Iceland
  • India
  • Jordan
  • Korea, Republic of
  • Kuwait
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Moldova, Republic of
  • Monaco
  • Morocco
  • Qatar
  • Saint Lucia
  • Saudi Arabia
  • Seychelles
  • Slovakia
  • Sri Lanka
  • Sweden
  • Trinidad and Tobago
  • Turkey
  • United Kingdom, UK
  • United States, US
View All Countries

Latest news releases on Irinotecan:

Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan. - Genetic Engineering News

AUSTIN, Texas, May 22, 2012 /PRNewswire/ -- Prodigy Generics, a division of Prodigy Health Supplier Corporation (PHS), has launched injectable irinotecan. Irinotecan is the generic equivalent of the branded drug Camptosar by Pfizer. Prodigy ...

Sagent Pharmaceuticals Announces Launch of Irinotecan Hydrochloride Injection in Single Dose Vials - Yahoo Finance

SCHAUMBURG, Ill., May 17, 2012 (GLOBE NEWSWIRE) -- Sagent Pharmaceuticals, Inc. (Nasdaq:SGNT - News) today announced the launch of Irinotecan Injection, the generic form of the chemotherapy drug Camptosar(R), in two latex free, preservative free ...

Sagent Pharma launches irinotecan Hcl injection in single dose vials - pharmabiz.com

Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, has launched irinotecan injection, the generic form of the chemotherapy drug Camptosar, in two latex free ...

Sagent Launches Irinotecan Hydrochloride Injection In Single Dose Vials - RTT News

(RTTNews) - Sagent Pharmaceuticals Inc. (SGNT: News ) announced the launch of Irinotecan Injection, the generic form of the chemotherapy drug Camptosar, in two latex free, preservative free single dose vials. According to IMS data for the twelve-months ...

GI Cancers: Promising Data Across the Board - Medscape News

[6] There will be an Intergroup report looking at the adjuvant chemotherapy comparators of conventional 5-fluorouracil leucovorin vs a much more complex dose-intense regime looking at irinotecan and 5-fluorouracil leucovorin, followed sequentially by ...

Alchemia Limited : Open Briefing - 4-traders (press release)

Alchemia Limited (ACL) yesterday announced that the independent Data Safety Monitoring Board (DSMB) for the Phase III clinical trial of its lead cancer drug, HA-Irinotecan, in second or third line metastatic colorectal cancer, has approved the continuation ...

A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma - BioMed Central

5-fluorouracil, leucovorin, irinotecan and oxaliplatin (FOLFIRINOX) is superior to gemcitabine in patients with metastatic pancreatic cancer who have a good performance status. We investigated this combination as neoadjuvant therapy for locally advanced ...

Research and Markets: Afinitor (Pancreatic Cancer) - Analysis and Forecasts to 2020 - CNBC

Irinotecan, Sutent, GV1001, Afinitor, Avastin, AMG479, Abraxane, Masitinib, Gemzar, Nexavar, S-1, Tarceva, Certican, Novartis For more information visit

New cancer drugs held up by the NHS for nine years as rationing body accused of letting down patients - Daily Mail

The average delay for multiple drugs given the green light in 2005 was 8.7 years. They included treatments for bowel cancer (irinotecan and oxaliplatin) and cancer of the womb (topotecan and pacilitaxel). In 2006 NICE approved three Alzheimer’s drugs ...

Major Milestone Reached in Salient Pharmaceuticals' Phase II Trial - PR-USA.net

Launched in February 2009, the Phase II trial is studying the ability of Salient’s product to prevent and/or treat diarrhea in metastatic colorectal cancer patients receiving irinotecan®. It is being supported by the National Cancer Institute’s ...

Customer Service
1-866-799-3435 - Use Discount Code 7500 | Contact Form
Copyright © 2012 ExpressMedsCanada.com All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK